CARDIOPHARMA ApS: Financial statements 2017
CVR: 13966273
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
CARDIOPHARMA ApS (CVR 13966273) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 947,137 and a net result of DKK 2,463,901 compared with DKK 2,214,054 the year before. That is a decrease of 78.7% compared with the year before. Equity in the 2017 report amounted to DKK 23,164,468. The solvency ratio was 95.3%.
- Gross Profit
- DKK 947,137
- Profit/Loss
- DKK 2,463,901
- Equity
- DKK 23,164,468
- Total Assets
- DKK 24,314,017
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 947 t. | 2.5 mio. | 23.2 mio. | - |
| 2016 | - | 4.5 mio. | 2.2 mio. | 21.4 mio. | - |
| 2015 | - | 1 mio. | 2.9 mio. | 20.2 mio. | - |
| 2014 | - | 0 | 3 mio. | 18.8 mio. | - |
| 2013 | - | 50 t. | 2.5 mio. | 15.8 mio. | - |
Official annual report
Keep an eye on CARDIOPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout CARDIOPHARMA ApS
CARDIOPHARMA ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 1990. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named KM 455 ApS. The management consists of Niels Christian Fischer Petersen. The company is owned by Niels Christian Fischer Petersen. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 4,336,132 and a net result of DKK 3,090,043 compared with DKK 1,968,388 the year before. Equity in the 2026 report amounted to DKK 31,593,726.